Get started
Author

Jaume Barallat

Observed names: Barallat, Jaume, J Barallat, J. Barallat, J. Barallat Martínez De Osaba, Jaume Barallat Martinez de Osaba, Jaume Barallat Martínez, Jaume Barallat Martínez De Osaba, Jaume Barallat Martínez de Osaba
Observed institutions: Universitat Autònoma de Barcelona, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, Institut Universitari d'Investigació en Atenció Primària Jordi Gol, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Hôpital Bichat-Claude-Bernard, Institut Català de la Salut, Hospital Universitari Germans Trias i Pujol
ORCID: 0000-0003-3493-5958
Observed ORCID: 0000-0003-3493-5958
OpenAlex ID: A5066933990
Head-to-Head Comparison of 2 Myocardial Fibrosis Biomarkers for Long-Term Heart Failure Risk Stratification
2013 · Antoni Bayes-Genis, Marta de Antonio, et al. · Journal of the American College of Cardiology · 268
PDF
A Test in Context: Neprilysin
2016 · Antoni Bayes-Genis, Jaume Barallat, et al. · Journal of the American College of Cardiology · 244
PDF
Soluble Neprilysin Is Predictive of Cardiovascular Death and Heart Failure Hospitalization in Heart Failure Patients
2015 · Antoni Bayés-Genís, Jaume Barallat, et al. · Journal of the American College of Cardiology · 168
PDF
Clinical Role of CA125 in Worsening Heart Failure
2020 · Julio Núñez, Antoni Bayés-Genís, et al. · JACC Heart Failure · 126
PDF
Biological Signatures of Asymptomatic Extra- and Intracranial Atherosclerosis
2012 · Elena López-Cancio, Amparo Galán, et al. · Stroke · 90
PDF
Impact of diabetes on the predictive value of heart failure biomarkers
2016 · Nuria Alonso, Josep Lupón, et al. · Cardiovascular Diabetology · 63
PDF
The Dynamics of Cardiovascular Biomarkers in non-Elite Marathon Runners
2017 · Emma Roca, Lexa Nescolarde, et al. · Journal of Cardiovascular Translational Research · 61
Prognostic Value and Kinetics of Soluble Neprilysin in Acute Heart Failure
2015 · Antoni Bayés-Genís, Jaume Barallat, et al. · JACC Heart Failure · 54
Predicción de bacteriemia en los pacientes con sospecha de infección en urgencias
2010 · Pere Tudela, Alicia Lacoma, et al. · Medicina Clínica · 52
Predictive biomarkers for death and rehospitalization in comorbid frail elderly heart failure patients
2018 · Cristina Pacho, Mar Domingo, et al. · BMC Geriatrics · 50
PDF
Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction
2018 · Pedro Moliner, Josep Lupón, et al. · International Journal of Cardiology · 46
Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave
2020 · J Barallat, G Fernández-Rivas, et al. · PLoS ONE · 39
PDF
Low Levels of Few Micronutrients May Impact COVID-19 Disease Progression: An Observational Study on the First Wave
2021 · Teresa-Maria Tomasa-Irriguible, Lara Bielsa-Berrocal, et al. · Metabolites · 38
PDF
Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP
2015 · Antoni Bayes-Genis, Jaume Barallat, et al. · Revista Española de Cardiología (English Edition) · 37
Pre-analytical considerations in biomarker research: focus on cardiovascular disease
2021 · Elena Revuelta-López, Jaume Barallat, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 35
PDF
Barcelona Bio-Hf Calculator Version 2.0: Incorporation of Angiotensin Ii Receptor Blocker Neprilysin Inhibitor (Arni) and Risk for Heart Failure Hospitalization
2017 · Josep Lupón, Joanne Simpson, et al. · European Journal of Heart Failure · 31
PDF
Dual chronoamperometric detection of enzymatic biomarkers using magnetic beads and a low-cost flow cell
2015 · Javier Moral-Vico, Jaume Barallat, et al. · Biosensors and Bioelectronics · 31
Serum Neprilysin and Recurrent Admissions in Patients With Heart Failure
2017 · Julio Núñez, Eduardo Núñez, et al. · Journal of the American Heart Association · 30
Estrategia multimarcador para estratificar el pronóstico en insuficiencia cardiaca. Valor de los marcadores neurohumorales: neprilisina frente a NT-proBNP
2015 · Antoni Bayes-Genis, Jaume Barallat, et al. · Revista Española de Cardiología · 28
Chronoamperometric Magneto Immunosensor for Myeloperoxidase Detection in Human Plasma Based on a Magnetic Switch Produced by 3D Laser Sintering
2013 · Jaume Barallat, Rosa Olivé-Monllau, et al. · Analytical Chemistry · 28
Bloodstream Amyloid-beta (1-40) Peptide, Cognition, and Outcomes in Heart Failure
2017 · Antoni Bayes-Genis, Jaume Barallat, et al. · Revista Española de Cardiología (English Edition) · 27
Elevated Neopterin Levels Predict Fatal Outcome in SARS-CoV-2-Infected Patients
2021 · Manon Chauvin, Martin Larsen, et al. · Frontiers in Cellular and Infection Microbiology · 25
PDF
Soluble neprilysin retains catalytic activity in heart failure
2016 · Antoni Bayes-Genis, Timothy C. Prickett, et al. · The Journal of Heart and Lung Transplantation · 25
A bio-clinical approach for prediction of sudden cardiac death in outpatients with heart failure: The ST2-SCD score
2019 · Josep Lupón, Germán Cediel, et al. · International Journal of Cardiology · 24
Multi-Biomarker Profiling and Recurrent Hospitalizations in Heart Failure
2016 · Antoni Bayes-Genis, Julio Núñez, et al. · Frontiers in Cardiovascular Medicine · 18
PDF
Works count: 61
Citation count: 1,780
H-index: 24
I10-index: 29
Year
Topic
Type